How Many Sessions and What Interval Should Stem Cell Conditioned Media Joint Injections Follow? — Dr. Moriwaki Explains the Induction/Maintenance Framework and Effect Assessment2026.07.13
“I’m considering joint injection, but how many sessions do I really need to feel results?” “How long should the interval between injections be?” — these are questions we hear often from patients considering joint injection therapy with stem cell conditioned media. The truth is, there is no single “fixed number of sessions” or “absolute interval” that applies to everyone; the number and spacing must be designed based on the target joint, disease stage, lifestyle background, and treatment goals. Here, Dr. Shin Moriwaki of AVAN TOKYO Ginza outlines a framework of dividing joint injection therapy into an “induction phase” and a “maintenance phase,” together with a practical way of assessing effects through the three axes of pain, range of motion, and daily activities — while avoiding the assertive tone typical of medical advertisements.
Key Points of This Article
・Stem cell conditioned media joint injection is neither a “one-and-done” treatment nor something to be repeated indefinitely; a session design tailored to the joint and disease stage is essential
・The basic framework is a “two-phase design”: multiple sessions at intervals of a few weeks to one month during the induction phase, and intervals of several months during the maintenance phase
・Effect assessment should be three-dimensional, combining pain score, range of motion, and ease of daily activities
・If response remains poor after three months, do not simply continue — reassess the diagnosis, injection site, and combined therapies
・Definitive claims of “guaranteed cure in X sessions” cannot be supported by current evidence; this is a field that requires honesty about individual variation and limits
There Is No “Absolute Correct Number” for Joint Injection Sessions
First, it should be noted that stem cell conditioned media joint injection does not fit the simple “one vial = one complete treatment” design of ordinary drugs. Because this treatment aims for a biological effect — calming intra-articular inflammation and adjusting the microenvironment involved in tissue repair — there is a time lag between administration and onset of effect, and the duration of effect varies between individuals.
Even within the same diagnosis of knee osteoarthritis, the required number and interval of joint injection sessions differ according to Kellgren-Lawrence grade (degree of cartilage wear), age, body size, activity level, intensity of inflammation, and past treatment history. The shoulder joint cavity and subacromial bursa differ both in volume and in turnover rate; tendon attachment sites and intra-articular spaces differ in blood supply. Uniform package deals like “three-session set” are easy to understand but risk creating false expectations, so we handle them cautiously at our clinic.
Changing Intervals Between Induction and Maintenance: The “Two-Phase Design”
Induction Phase: Weekly Intervals to Break the Inflammation Cycle
In the early “induction phase” of treatment, the priority is to first control pain and inflammation. In many joint pain cases, we administer multiple sessions at 2- to 4-week intervals after the first injection, evaluating changes in pain and range of motion. Because the intra-articular inflammation cycle is self-amplifying, spacing sessions too far apart can allow inflammation to reignite before the next administration.
However, this does not mean “three sessions are mandatory.” Some patients experience solid symptom relief and no interference in daily activities after just one or two joint injections; conversely, cases with advanced knee deformity may not achieve sufficient analgesia even with multiple sessions, prompting consideration of alternative treatments.
Maintenance Phase: Widening the Interval to Several Months
Once symptoms stabilize during the induction phase, we transition to the “maintenance phase.” Maintenance injections are often given preventively, before pain flares up again. Depending on the target joint and the patient’s activity level, an interval of 3-6 months is one common guide.
A useful reference in maintenance-phase interval design is the patient’s own longitudinal data — “how long did the last effect last?” For someone whose discomfort returned four months after the previous injection, we may propose additional injections every 3-4 months; for someone comfortable for over six months, a longer interval. The patient’s own course is treated as the primary guide.
Effect Assessment: A Three-Dimensional View Through Pain, Range of Motion, and Daily Activities
Judging the effect of joint injection therapy solely by “whether pain decreased” can miss cases where treatment is genuinely working. Conversely, celebrating a single “low-pain day” risks overestimating actual functional improvement. Practically speaking, effect assessment should combine the following three axes.
1. Pain Score (NRS or VAS)
This method records pain on a 10-point scale during the most painful scenes of daily life — climbing stairs, standing up, turning in bed, and so on. Numerical scoring makes it objectively easier to track “how much has changed compared to the previous visit.”
2. Range of Motion (ROM)
We measure the range each joint can move — shoulder abduction, knee flexion, hip external rotation, and so on. If pain decreases but ROM does not expand, contractures around the joint or muscle weakness likely remain, and combined rehabilitation becomes necessary.
3. Ease of Daily Activities (ADL/QOL)
Changes such as “I can put on socks while standing on one leg,” “I can grab the train strap again,” or “I no longer wake up at night from pain” are the assessment axis most tangibly felt by patients. By carefully checking these hard-to-quantify aspects at each visit, we can share the meaning of treatment with the patient.
Reassessment Flow When Treatment “Isn’t Working”
When symptoms do not improve as expected after several induction-phase joint injections, simply repeating the same content is not rational. Around the three-month mark, we reassess in the following three steps.
Step 1: Re-verify the Diagnosis Itself
Cases where the initial diagnosis was “intra-articular knee osteoarthritis” but the true dominant source was extra-articular pain such as pes anserine bursitis or enthesopathy are not rare in clinical practice. Similarly, low back pain assumed to be facet-joint-related may turn out to be sacroiliac or nerve-root in origin. When response is poor, the rule of thumb is to first suspect a diagnostic mismatch. We reconfirm disease concepts with reference to the guidelines of the Japanese Orthopaedic Association and add imaging as needed.
Step 2: Reconsider Injection Site and Dose
Even for the same joint, the effect changes depending on whether we target intra-articular, peri-articular, or tendon-attachment tissue. We use ultrasound guidance to confirm delivery reaches the intended layer, and switch injection sites when necessary.
Step 3: Add Combined Therapy or Refer for Orthopaedic Re-evaluation
Rather than closing the treatment within joint injection alone, we consider adding exercise therapy, bracing, extracorporeal shock wave therapy, and sometimes referral to surgical treatment. Especially in advanced knee osteoarthritis or extensive rotator cuff tears, we honestly acknowledge the limits of conservative therapy and coordinate with orthopaedic surgeons as needed.
Situations That Warrant Widening the Interval or Postponement
Separate from the induction/maintenance design, the following situations call for widening intervals or temporarily postponing joint injection.
・Fever or signs of acute periarticular infection
・Unstable overall condition (poorly controlled diabetes, immunodeficiency, etc.)
・End-stage joint destruction where conservative therapy has limited value
・Pregnancy or lactation, when cautious administration is required
・History of strong allergic reaction to prior administration
In these situations, continuing injections “on schedule” is not in the patient’s interest, so we pause to reassess overall condition and indication. For details on exclusion criteria, please see our related page. Learn more about stem cell conditioned media joint injection here.
Discuss Session Count and Interval as a “Treatment Plan” at the First Visit
The number and spacing of joint injection sessions should not be decided one session at a time after the patient has already received the first shot. It is important to share at the first visit “what goal we are aiming for, and over how much time and how many sessions.” An open-ended design of “receive injections until pain is zero” increases the patient’s financial and physical burden.
At our clinic, we share with patients at the first visit what will be evaluated at 3 months, 6 months, and 1 year, and determine in advance the decision points for “continue,” “modify,” or “pause.” Understanding joint injection as a treatment that is “used with appropriate frequency and interval while confirming effects,” rather than “continued until it works,” ultimately raises patient satisfaction.
Frequently Asked Questions
Q. What is the minimum number of stem cell conditioned media joint injection sessions before I feel results?
It depends on the target joint, disease stage, and severity of symptoms, but typically we give several injections at 2-4 week intervals during the induction phase and evaluate effects around 8-12 weeks. Some feel clear change after one session, others only after several. No responsible clinician can promise “you will definitely feel results in X sessions.”
Q. Does receiving multiple sessions in a short period during the induction phase raise the risk of side effects?
As long as appropriate intervals (2-4 weeks) are maintained and the injection site is managed cleanly, side effects of the stem cell conditioned media itself are thought to be limited. However, repeated needle punctures at the same site carry risks of bruising, infection, and transient pain flare, so we avoid excessively shortening intervals to increase session count.
Q. What interval should be maintained during the maintenance phase of joint injection?
Depending on the target joint and activity level, every 3-6 months is one guide. The primary compass for determining the interval is the length of comfortable time achieved after the previous injection.
Q. If I stop treatment midway, will my joint return to its original state?
Joint injection therapy is neither something that “only works while you continue receiving it” nor something that “permanently cures with one shot.” After discontinuation, symptoms may return in line with re-ignition of the intra-articular inflammation cycle or the natural progression of joint deformity. Designing the timing of discontinuation as part of the treatment plan is important.
Q. When should I decide to stop if I don’t feel any effect?
As a general rule, if there is no clear improvement three months after several induction-phase joint injections, we do not simply continue on autopilot; instead, we review the diagnosis, injection site, and combined therapies. We also consider switching to other treatments or arranging orthopaedic re-evaluation.
──────────────
[Supervising Physician] Shin Moriwaki, MD (Supervising Physician)
Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine
U.S. Medical License Qualification (ECFMG certificate)
──────────────
📍AVAN TOKYO 銀座 再生医療
AVAN TOKYO Ginza Regenerative Medicine
English / 中文 / Tiếng Việt available
Inquiries welcome via DM / LINE / Website / Phone.